Pages that link to "Q41741674"

The following pages link to Diagnoses, procedures, drug utilization, comorbidities, and cost of health care for people with epilepsy in 2012. (Q41741674):

Displaying 13 items.

• The direct cost of epilepsy in the United States: A systematic review of estimates (Q26799129) (← links)
• Approaches to Supporting the Analysis of Historical Medication Datasets with RxNorm (Q35950630) (← links)
• Co-morbidity and clinically significant interactions between antiepileptic drugs and other drugs in elderly patients with newly diagnosed epilepsy (Q38722185) (← links)
• Analgesic opioid use in a health-insured epilepsy population during 2012. (Q38763313) (← links)
• Killing two birds with one stone: successful opioid monotherapy in intractable migraine-triggered epilepsy, a case series (Q39137721) (← links)
• PatientsLikeMe® Online Epilepsy Community: Patient characteristics and predictors of poor health-related quality of life (Q39470002) (← links)
• Health resource utilization varies by comorbidities in children with epilepsy (Q39939624) (← links)
• Accuracy of Conventional Diagnostic Methods for Identifying Structural Changes in Patients with Focal Epilepsy (Q40445814) (← links)
• Cost-effectiveness analysis of epilepsy surgery in a controlled cohort of adult patients with intractable partial epilepsy: A 5-year follow-up study. (Q40863808) (← links)
• Optical triggered seizures using a caged 4-Aminopyridine (Q43131293) (← links)
• Lacosamide and concomitant use of antiepileptic and other medications in a US population - A retrospective cohort study. (Q50605147) (← links)
• Prevalence and Economic Burden of Epilepsy in the Institutionalized Medicare Fee-for-Service Population (Q92187425) (← links)
• Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study (Q97094910) (← links)